Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-2-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0004-1858
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
185-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2532198-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:2532198-Aerosols,
pubmed-meshheading:2532198-Arkansas,
pubmed-meshheading:2532198-Forecasting,
pubmed-meshheading:2532198-Humans,
pubmed-meshheading:2532198-Pentamidine,
pubmed-meshheading:2532198-Pneumonia, Pneumocystis
|
pubmed:year |
1989
|
pubmed:articleTitle |
AIDS in Arkansas. AMS Committee on AIDS. Update: October 1989. Pentamidine aerosol: innovation, experimentation and the future.
|
pubmed:publicationType |
Journal Article
|